IS5482A - Composition of active ingredients especially of tetrahydropyridine and acetylcholine esterase inhibitory agent for the treatment of dementia such as Alzheimer's dementia - Google Patents

Composition of active ingredients especially of tetrahydropyridine and acetylcholine esterase inhibitory agent for the treatment of dementia such as Alzheimer's dementia

Info

Publication number: IS5482A
Authority: IS; Iceland
Prior art keywords: dementia; tetrahydropyridine; alzheimer; treatment; composition
Prior art date: 1997-11-14

Application number

IS5482A

Other languages

Icelandic (is)

Inventor

Maffrand Jean-Pierre

Soubrie Philippe

Terranova Jean-Paul

Original Assignee

Sanofi-Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-14

Filing date

2000-05-09

Publication date

2000-05-09

1997-11-14 Priority claimed from FR9714324A external-priority patent/FR2771006B1/en

1997-11-14 Priority claimed from FR9714322A external-priority patent/FR2771007B1/en

2000-05-09 Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis

2000-05-09 Publication of IS5482A publication Critical patent/IS5482A/en

Links

VSWICNJIUPRZIK-UHFFFAOYSA-N 2-piperideine Chemical compound C1CNC=CC1 VSWICNJIUPRZIK-UHFFFAOYSA-N 0.000 title 1
208000024827 Alzheimer disease Diseases 0.000 title 1
206010012289 Dementia Diseases 0.000 title 1
108090000371 Esterases Proteins 0.000 title 1
OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 title 1
229960004373 acetylcholine Drugs 0.000 title 1
239000004480 active ingredient Substances 0.000 title 1
230000002401 inhibitory effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IS5482A 1997-11-14 2000-05-09 Composition of active ingredients especially of tetrahydropyridine and acetylcholine esterase inhibitory agent for the treatment of dementia such as Alzheimer's dementia IS5482A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR9714324A FR2771006B1 (en)	1997-11-14	1997-11-14	COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE
FR9714322A FR2771007B1 (en)	1997-11-14	1997-11-14	COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE
PCT/FR1998/002384 WO1999025363A1 (en)	1997-11-14	1998-11-09	Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia

Publications (1)

Publication Number	Publication Date
IS5482A true IS5482A (en)	2000-05-09

Family

ID=26233932

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5482A IS5482A (en)	1997-11-14	2000-05-09	Composition of active ingredients especially of tetrahydropyridine and acetylcholine esterase inhibitory agent for the treatment of dementia such as Alzheimer's dementia

Country Status (27)

Country	Link
EP (1)	EP1030671A1 (en)
JP (1)	JP2001523642A (en)
KR (1)	KR100599350B1 (en)
CN (1)	CN1243540C (en)
AU (1)	AU743228B2 (en)
BG (1)	BG64819B1 (en)
BR (1)	BR9814035A (en)
CA (1)	CA2309966A1 (en)
CO (1)	CO4980891A1 (en)
DZ (1)	DZ2649A1 (en)
EA (1)	EA003255B1 (en)
EE (1)	EE04235B1 (en)
HU (1)	HUP0100098A3 (en)
ID (1)	ID24933A (en)
IL (2)	IL136122A0 (en)
IS (1)	IS5482A (en)
MY (1)	MY120461A (en)
NO (1)	NO20002450L (en)
NZ (1)	NZ504420A (en)
OA (1)	OA11464A (en)
PL (1)	PL194597B1 (en)
SA (1)	SA98190747B1 (en)
SK (1)	SK286040B6 (en)
TR (1)	TR200001262T2 (en)
TW (1)	TW585766B (en)
UY (1)	UY25247A1 (en)
WO (1)	WO1999025363A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003105830A1 (en) *	2002-06-14	2003-12-24	富山化学工業株式会社	Medicinal compositions improving brain function and method for improving brain function
US20060160079A1 (en) *	2002-08-07	2006-07-20	Lane Roger M	Methods for the treatment of dementia based on apo e genotype
CN1520818A (en) *	2003-02-09	2004-08-18	ɽ��Ҷ��Ȼҩ��о��޹�˾	Cholinesterase inhibitor pharmaceutical composition for treating senile dementia
US8481565B2 (en)	2004-12-27	2013-07-09	Eisai R&D Management Co., Ltd.	Method for stabilizing anti-dementia drug
AU2015210852B2 (en)	2014-01-31	2019-01-24	Cognition Therapeutics, Inc.	Isoindoline compositions and methods for treating neurodegenerative disease
DK3634394T3 (en)	2017-05-15	2026-03-02	Cognition Therapeutics Inc	COMPOSITIONS FOR TREATING NEUROGENERATE DISEASES
KR102224917B1 (en)	2018-03-20	2021-03-09	(주)인벤티지랩	Production methods of preventing or treating cognitive impairment-related disease and preventing or treating cognitive impairment-related disease producing thereto
WO2019182319A1 (en) *	2018-03-20	2019-09-26	(주)인벤티지랩	Method for preparing pharmaceutical composition for preventing or treating cognitive disorder-associated diseases, and pharmaceutical composition for preventing or treating cognitive disorder-associated diseases, prepared by preparation method
CN109265391B (en) *	2018-11-13	2021-11-19	枣庄学院	Biphenyl polysubstituted 1,2,5, 6-tetrahydropyridine compound and synthetic method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2662355B1 (en) *	1990-05-22	1994-11-10	Sanofi Sa	USE OF 1- [2- (2-NAPHTYL) ETHYL] -4- (3-TRIFLUOROMETHYLPHENYL) -1,2,3,6-TETRAHYDROPYRIDINE FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF BRAIN AND NEURAL DISORDERS.
US5453428A (en) *	1991-02-14	1995-09-26	The Mount Sinai School Of Medicine Of The City Of New York	Method and composition for the treatment of apathy-amotivation syndrome
CA2213000A1 (en) *	1995-03-06	1996-09-12	Interneuron Pharmaceuticals, Inc.	Reduction of infarct volume using citicoline
FR2736053B1 (en) *	1995-06-28	1997-09-19	Sanofi Sa	NEWS 1-PHENYLALKYL-1,2,3,6-TETRAHYDROPYRIDINES

1998
- 1998-10-26 CO CO98062479A patent/CO4980891A1/en unknown
- 1998-10-28 TW TW087117874A patent/TW585766B/en not_active IP Right Cessation
- 1998-11-09 SK SK711-2000A patent/SK286040B6/en unknown
- 1998-11-09 CN CNB988130947A patent/CN1243540C/en not_active Expired - Fee Related
- 1998-11-09 JP JP2000520796A patent/JP2001523642A/en not_active Withdrawn
- 1998-11-09 EA EA200000412A patent/EA003255B1/en not_active IP Right Cessation
- 1998-11-09 WO PCT/FR1998/002384 patent/WO1999025363A1/en not_active Ceased
- 1998-11-09 CA CA002309966A patent/CA2309966A1/en not_active Abandoned
- 1998-11-09 NZ NZ504420A patent/NZ504420A/en unknown
- 1998-11-09 TR TR2000/01262T patent/TR200001262T2/en unknown
- 1998-11-09 BR BR9814035-3A patent/BR9814035A/en not_active Application Discontinuation
- 1998-11-09 HU HU0100098A patent/HUP0100098A3/en unknown
- 1998-11-09 AU AU11609/99A patent/AU743228B2/en not_active Ceased
- 1998-11-09 EP EP98954538A patent/EP1030671A1/en not_active Withdrawn
- 1998-11-09 KR KR1020007005231A patent/KR100599350B1/en not_active Expired - Fee Related
- 1998-11-09 ID IDW20000860A patent/ID24933A/en unknown
- 1998-11-09 EE EEP200000290A patent/EE04235B1/en not_active IP Right Cessation
- 1998-11-09 PL PL98340500A patent/PL194597B1/en not_active IP Right Cessation
- 1998-11-09 IL IL13612298A patent/IL136122A0/en not_active IP Right Cessation
- 1998-11-11 DZ DZ980259A patent/DZ2649A1/en active
- 1998-11-12 UY UY25247A patent/UY25247A1/en not_active IP Right Cessation
- 1998-11-14 MY MYPI98005180A patent/MY120461A/en unknown
- 1998-11-14 SA SA98190747A patent/SA98190747B1/en unknown
2000
- 2000-05-09 IS IS5482A patent/IS5482A/en unknown
- 2000-05-11 NO NO20002450A patent/NO20002450L/en unknown
- 2000-05-11 BG BG104428A patent/BG64819B1/en unknown
- 2000-05-12 OA OA1200000141A patent/OA11464A/en unknown
- 2000-05-14 IL IL136122A patent/IL136122A/en unknown

Also Published As

Publication number	Publication date
BG64819B1 (en)	2006-05-31
PL194597B1 (en)	2007-06-29
EP1030671A1 (en)	2000-08-30
IL136122A (en)	2006-07-05
SA98190747B1 (en)	2006-11-04
MY120461A (en)	2005-10-31
DZ2649A1 (en)	2004-12-28
CA2309966A1 (en)	1999-05-27
JP2001523642A (en)	2001-11-27
ID24933A (en)	2000-08-31
PL340500A1 (en)	2001-02-12
AU743228B2 (en)	2002-01-24
OA11464A (en)	2003-11-18
EA200000412A1 (en)	2000-12-25
SK7112000A3 (en)	2000-10-09
KR100599350B1 (en)	2006-07-12
EE200000290A (en)	2001-06-15
IL136122A0 (en)	2001-05-20
BR9814035A (en)	2000-09-26
TW585766B (en)	2004-05-01
WO1999025363A1 (en)	1999-05-27
CO4980891A1 (en)	2000-11-27
UY25247A1 (en)	2001-05-31
CN1243540C (en)	2006-03-01
BG104428A (en)	2001-08-31
NO20002450D0 (en)	2000-05-11
NZ504420A (en)	2003-08-29
CN1285742A (en)	2001-02-28
HUP0100098A3 (en)	2001-12-28
HUP0100098A2 (en)	2001-07-30
NO20002450L (en)	2000-07-14
EE04235B1 (en)	2004-02-16
KR20010032099A (en)	2001-04-16
AU1160999A (en)	1999-06-07
EA003255B1 (en)	2003-02-27
TR200001262T2 (en)	2001-01-22
SK286040B6 (en)	2008-01-07

Publication	Publication Date	Title
DK1123313T3 (en)	2007-06-18	Methods and compositions for the prevention and treatment of anemia
DE69612185D1 (en)	2001-04-26	BLEACHING METHOD AND BLENDER COMPOSITION
DK1112174T3 (en)	2009-11-02	Isosorbide-containing polyesters and processes for their preparation
DE69739583D1 (en)	2009-10-29	TOPICAL COMPOSITIONS CONTAIN AS A THERAPEUTICALLY ACTIVE AGENT A MONOGLYCERIDE FOR THE TREATMENT OF SLEW-TONE INFECTIONS
DK0622408T3 (en)	2002-11-04	Composition and process for the preparation of gelatin-free soft capsules
DE69638351D1 (en)	2011-05-19	AS WELL AS FOR RESISTING THE DISTAL AND FRONT FEMUR
DE69413051D1 (en)	1998-10-08	DETERGENT COMPOSITIONS CONTAINING AGENTS FOR PREVENTING THE TURNING OF SILVER
ATE231393T1 (en)	2003-02-15	LIQUID COMPOSITION CONTAINING HIV PROTEASE INHIBITORS AND C12-C18 FATTY ACID
DE69617088D1 (en)	2002-01-03	Process for the preparation of crystallized maltitol and crystallines containing it.
DE69812784D1 (en)	2003-05-08	Composition for the prevention and elimination of plant diseases
GB2311940B (en)	2000-07-19	Pharmaceutical compositions for the treatment of rhinitis
ZA977310B (en)	1998-03-27	Transdermal propentofylline compositions for the treatment of Alzheimer's disease.
DE69405919D1 (en)	1997-11-06	Compositions for the treatment of keratin fibers
NO992504L (en)	1999-05-25	Compositions for the treatment of soil, process for its preparation, and use
DK1007040T3 (en)	2002-08-26	The use of phanquinone in the treatment of Alzheimer's disease
NO20002450L (en)	2000-07-14	Composition of active ingredients, in particular tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of senile dementia of Alzheimer's type
NO20001758D0 (en)	2000-04-05	Methods and compositions for the treatment of arthritis
DK0918521T3 (en)	2003-02-03	Formulation for the treatment and / or prevention of dementia
DE69802498D1 (en)	2001-12-20	COMBINATION PRODUCT CONTAINING IDEBENON FOR ALZHEIMER TREATMENT
WO2000033788A3 (en)	2000-10-19	Substituted nitrogen heterocyclic compounds and therapeutic uses thereof
NO20012099D0 (en)	2001-04-27	Process for the preparation of 4-arylpiperidine-3-carbinols and related compounds
EP0635567A3 (en)	1996-11-27	Method and composition for facilitating the removal of soil contaminants from solid surfaces.
FI944687A7 (en)	1995-04-08	Composition for the prevention and treatment of myopia
EP0634380A3 (en)	1995-08-16	Liquid composition for plant treatment and process of manufacturing thereof.
NO981499L (en)	1998-10-05	Process for the preparation of titanium dioxide